Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) |
Dec. 31, 2021 |
Dec. 31, 2020 |
|---|---|---|
| Income Tax Disclosure [Abstract] | ||
| Amortization | $ 460,537 | $ 586,174 |
| Net operating loss carryforward | 15,164,992 | 20,671,683 |
| Allowance for doubtful accounts | 401,436 | 403,991 |
| Charitable contributions | 644 | 624 |
| Stock options | 1,003,453 | 971,860 |
| Accrued liabilities | 1,711,890 | 312,419 |
| HHS Provider Relief Funds | 1,175,790 | |
| Employee retention credit | 292,282 | |
| R&D credit carryforward | 220,431 | |
| VisualMed Basis Difference | 878,709 | |
| Deferred state tax asset | 3,683,024 | 5,117,347 |
| Total deferred income tax assets | 23,596,967 | 29,460,319 |
| Depreciation | (691,456) | (1,498,698) |
| Deferred tax asset, net | 22,905,511 | 27,961,621 |
| Less: valuation allowance | (22,905,511) | (27,961,621) |
| Net deferred tax assets |
| X | ||||||||||
- Definition Depreciation. No definition available.
|
| X | ||||||||||
- Definition Amortization. No definition available.
|
| X | ||||||||||
- Definition VisualMed basis difference. No definition available.
|
| X | ||||||||||
- Definition Employee retention credit. No definition available.
|
| X | ||||||||||
- Definition HHS Provider Relief Funds. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|